Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
24
TOVX Quote, Financials, Valuation and Earnings
Last price:
$0.49
Seasonality move
:
11067.83%
Day range:
$0.46 - $0.48
52-week range:
$0.40 - $7.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.33x
P/B ratio:
0.25x
Volume:
106.1K
Avg. volume:
445.2K
1-year change:
-93.37%
Market cap:
$3.8M
Revenue:
--
EPS (TTM):
-$20.71
Earnings Data
Next earnings date for TOVX
Aug 13
2025
Most recent earnings per share
-$1.55
Beat by $0.01
(May 14/2025)
Consensus Estimate
-$1.56
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TOVX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.43 | -- |
| 08/13/2025 | Q2 | -- | -- | -- | -$0.47 | -- |
| 05/14/2025 | Q1 | -- | -- | -$1.55 | -$1.56 | $0.01 |
| 03/06/2025 | Q4 | -- | -- | -$1.60 | -- | -- |
| 11/12/2024 | Q3 | -- | -- | -$6.81 | -$5.25 | -$1.56 |
| 08/13/2024 | Q2 | -- | -- | -$10.75 | -- | -- |
| 05/07/2024 | Q1 | -- | -- | -$7.53 | -$8.50 | $0.97 |
| 03/25/2024 | Q4 | -- | -- | -$8.10 | -$8.25 | $0.15 |
| 11/13/2023 | Q3 | -- | -- | -$4.85 | -$8.50 | $3.65 |
| 08/11/2023 | Q2 | -- | -- | -$8.50 | -$8.50 | -- |
| 05/16/2023 | Q1 | -- | -- | -$7.50 | -$8.00 | $0.50 |
| 03/16/2023 | Q4 | -- | -- | -$11.00 | -- | -- |
| 11/03/2022 | Q3 | -- | -- | -$7.50 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$7.00 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$7.75 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$9.75 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$6.25 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$6.00 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$32.50 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$35.00 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$35.00 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$45.00 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$50.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$47.50 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$77.50 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$57.50 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$62.50 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$240.86 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$232.50 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$290.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$162.50 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $192.50 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$1,225.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$262.50 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$175.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$177.37 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$799.33 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$875.01 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$1,050.02 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$1,058.00 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$1,050.02 | -- | -- |
Theriva Biologics Earnings Questions
-
How Much did Theriva Biologics Generate in Revenue Last Quarter?
Theriva Biologics reported -- worth of top line sales in its most recent quarter.
-
Did Theriva Biologics Beat Earnings Last Quarter?
Theriva Biologics announced earnings per share of -$1.55 which represents a beat of analyst forecast a -$1.56 per share.
-
Is Theriva Biologics Profitable?
Theriva Biologics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Theriva Biologics EPS Next Year?
Theriva Biologics's earnings are forecast to decrease from -$19.03 per share to -$2.20 per share next year representing a decrease of -88.44%.
-
When is Theriva Biologics's Earnings Date?
Theriva Biologics's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
